These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19737416)

  • 1. A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice.
    Soncin S; Lo Cicero V; Astori G; Soldati G; Gola M; Sürder D; Moccetti T
    J Transl Med; 2009 Sep; 7():78. PubMed ID: 19737416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete intra-laboratory validation of a LAL assay for bacterial endotoxin determination in EBV-specific cytotoxic T lymphocytes.
    Pasqua S; Niotta MC; Di Martino G; Sottile D; Douradinha B; Miele M; Timoneri F; Di Bella M; Cuscino N; Di Bartolo C; Conaldi PG; D'Apolito D
    Mol Ther Methods Clin Dev; 2021 Sep; 22():320-329. PubMed ID: 34514024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
    Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
    Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of analytical methods in compliance with good manufacturing practice: a practical approach.
    Rustichelli D; Castiglia S; Gunetti M; Mareschi K; Signorino E; Muraro M; Castello L; Sanavio F; Leone M; Ferrero I; Fagioli F
    J Transl Med; 2013 Aug; 11():197. PubMed ID: 23981284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries.
    Coppens DGM; Hoekman J; De Bruin ML; Slaper-Cortenbach ICM; Leufkens HGM; Meij P; Gardarsdottir H
    Cytotherapy; 2020 Oct; 22(10):592-600. PubMed ID: 32563611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GMP-conformant on-site manufacturing of a CD133
    Skorska A; Müller P; Gaebel R; Große J; Lemcke H; Lux CA; Bastian M; Hausburg F; Zarniko N; Bubritzki S; Ruch U; Tiedemann G; David R; Steinhoff G
    Stem Cell Res Ther; 2017 Feb; 8(1):33. PubMed ID: 28187777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance.
    Golay J; Pedrini O; Capelli C; Gotti E; Borleri G; Magri M; Vailati F; Passera M; Farina C; Rambaldi A; Introna M
    Cytotherapy; 2018 Feb; 20(2):262-270. PubMed ID: 29246649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing.
    Korbutt GS
    Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States.
    Iglesias-Lopez C; Obach M; Vallano A; Agustí A
    Cytotherapy; 2021 Mar; 23(3):261-274. PubMed ID: 33483292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality Control Testing for Tracking Endotoxin-Producing Gram-Negative Bacteria during the Preparation of Polyvalent Snake Antivenom Immunoglobulin.
    Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH
    PDA J Pharm Sci Technol; 2015; 69(4):499-510. PubMed ID: 26242786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of advanced therapy medicinal products in Europe and the role of academia.
    Pearce KF; Hildebrandt M; Greinix H; Scheding S; Koehl U; Worel N; Apperley J; Edinger M; Hauser A; Mischak-Weissinger E; Dickinson AM; Lowdell MW
    Cytotherapy; 2014 Mar; 16(3):289-97. PubMed ID: 24113428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical approach for gmp-compliant validation of real-time PCR method for mycoplasma detection in human mesenchymal stromal cells as advanced therapy medicinal product.
    Becherucci V; Curini L; Ceccantini R; Bisin S; Gori V; Gentile F; De Rienzo E; Piccini L; Bindi B; Pavan P; Cunial V; Allegro E; Ermini S; Brugnolo F; Bambi F
    Biologicals; 2021 Sep; 73():31-40. PubMed ID: 34362616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A proposal by the Japanese Pharmacopoeia for a method to set an endotoxin limit for parenteral drugs to be tested].
    Ogawa Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):210-2. PubMed ID: 9641849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of limulus amebocyte lysate and recombinant endotoxin alternative assays for an assessment of endotoxin detection specificity.
    Dubczak J; Reid N; Tsuchiya M
    Eur J Pharm Sci; 2021 Apr; 159():105716. PubMed ID: 33454378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte regeneration in pericicatricial zone of the myocardium after laser tunneling and implantation of bone marrow mononuclear cells.
    Larionov PM; Chernyavskii AM; Kuznetsova IV; Lushnikova EL; Bondar' VY; Uglova EV; Bocharova AV; Subbotina OA; Nepomnyashchikh LM; Karas'kov AM
    Bull Exp Biol Med; 2009 Oct; 148(4):692-6. PubMed ID: 20396772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the Integrity of Potency Assays to Safe Clinical Intervention: Legal Perspectives.
    Roslin W; Mansnérus J
    Adv Exp Med Biol; 2023; 1420():151-163. PubMed ID: 37258789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
    Cooper JF; Latta KS; Smith D
    Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralaboratory validation of kinetic chromogenic Limulus amebocyte lysate assay for bacterial endotoxin determination in anti-bothropic serum.
    Fingola FF; Albertino SR; Abrantes Sde M; Zamith HP
    J Pharm Biomed Anal; 2013 Nov; 85():93-8. PubMed ID: 23912057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.